ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Cipher Pharmaceuticals, Inc. ?
1
High Management Efficiency with a high ROE of 25.10%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 12.64
3
With ROE of 23.08%, it has a very attractive valuation with a 2.25 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -5.56%, its profits have risen by 230.9% ; the PEG ratio of the company is 0
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Cipher Pharmaceuticals, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Cipher Pharmaceuticals, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Cipher Pharmaceuticals, Inc.
-14.73%
1.32
44.46%
S&P/TSX 60
20.36%
2.51
12.02%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
20.33%
EBIT Growth (5y)
11.71%
EBIT to Interest (avg)
14.70
Debt to EBITDA (avg)
0.19
Net Debt to Equity (avg)
0.17
Sales to Capital Employed (avg)
0.31
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
28.37%
ROE (avg)
25.10%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
2.25
EV to EBIT
14.94
EV to EBITDA
10.94
EV to Capital Employed
2.31
EV to Sales
5.79
PEG Ratio
0.04
Dividend Yield
NA
ROCE (Latest)
15.45%
ROE (Latest)
23.08%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CAD 37.54 MM
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
NET PROFIT(9M)
Higher at CAD 32.57 MM
-9What is not working for the Company
CASH AND EQV(HY)
Lowest at CAD 21.87 MM
NET SALES(Q)
Lowest at CAD 16.71 MM
PRE-TAX PROFIT(Q)
Lowest at CAD 5.04 MM
NET PROFIT(Q)
Lowest at CAD 5.56 MM
EPS(Q)
Lowest at CAD 0.21
Here's what is working for Cipher Pharmaceuticals, Inc.
Operating Cash Flow
Highest at CAD 37.54 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CAD MM)
Here's what is not working for Cipher Pharmaceuticals, Inc.
Net Profit
At CAD 5.56 MM has Fallen at -48.02%
over average net sales of the previous four periods of CAD 10.69 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CAD MM)
Net Sales
Lowest at CAD 16.71 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CAD MM)
Pre-Tax Profit
Lowest at CAD 5.04 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CAD MM)
Pre-Tax Profit
At CAD 5.04 MM has Fallen at -27.81%
over average net sales of the previous four periods of CAD 6.99 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CAD MM)
Net Profit
Lowest at CAD 5.56 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CAD MM)
EPS
Lowest at CAD 0.21
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CAD)
Cash and Eqv
Lowest at CAD 21.87 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Footer loading
